A study mapping the use of digital technologies in neurology clinical trials
Lars Masanneck, MD, University Hospital Düsseldorf, Düsseldorf, Germany, discusses a study that mapped the use of digital technologies in clinical trials for neurological conditions like Alzheimer’s, multiple sclerosis, Parkinson’s, and epilepsy syndromes. He highlights that the application of such technologies in trials has significantly increased, with advancements in tracking modalities such as sleep, cognitive function, and speech analysis, making it particularly relevant for neurology. This interview took place at the Shaping the Future of Medicine (STFOM 2024) congress held in Leipzig, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
